Beth Muir

3.8k total citations · 2 hit papers
11 papers, 2.4k citations indexed

About

Beth Muir is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Beth Muir has authored 11 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Beth Muir's work include Lung Cancer Treatments and Mutations (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). Beth Muir is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). Beth Muir collaborates with scholars based in United States, Germany and Canada. Beth Muir's co-authors include Dennis C. Sgroi, Daniel A. Haber, Gromoslaw A. Smolen, Chu‐Xia Deng, Joan S. Brugge, Michael Overholtzer, Jianmin Zhang, Wenmei Li, Daphne W. Bell and Ross A. Okimoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Beth Muir

11 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon

2006 748 citations Michael Overholtzer, Jianmin Zhang et al. Proceedings of the National Academy of Sciences profile →
Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials

2005 518 citations Daphne W. Bell, Thomas J. Lynch et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beth Muir United States	11	1.3k	970	820	712	436	11	2.4k
Jens Quant Austria	9	1.1k 0.9×	732 0.8×	562 0.7×	684 1.0×	186 0.4×	15	2.0k
Yukinori Minoshima Japan	17	1.2k 0.9×	504 0.5×	213 0.3×	331 0.5×	272 0.6×	35	1.9k
Selma Pennacchietti Italy	10	1.1k 0.8×	565 0.6×	344 0.4×	195 0.3×	661 1.5×	11	1.9k
Jalila Adnane United States	18	1.4k 1.1×	939 1.0×	167 0.2×	248 0.3×	394 0.9×	23	2.1k
Dineli Wickramasinghe United States	17	953 0.7×	359 0.4×	312 0.4×	224 0.3×	161 0.4×	24	1.6k
Umesh Bhanot United States	18	1.0k 0.8×	704 0.7×	499 0.6×	115 0.2×	678 1.6×	44	1.9k
Amrita Desai United States	19	657 0.5×	1.3k 1.4×	1.1k 1.3×	147 0.2×	359 0.8×	36	2.3k
William Cruz‐Muñoz Canada	18	1.4k 1.1×	1.1k 1.1×	471 0.6×	123 0.2×	961 2.2×	23	2.5k
Lian‐Yue Yang China	31	1.7k 1.3×	424 0.4×	236 0.3×	263 0.4×	1.1k 2.5×	57	2.4k
Chun Jye Lim Singapore	17	1.4k 1.1×	832 0.9×	265 0.3×	1.9k 2.6×	228 0.5×	22	3.2k

Countries citing papers authored by Beth Muir

Since Specialization

Citations

This map shows the geographic impact of Beth Muir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Muir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Muir more than expected).

Fields of papers citing papers by Beth Muir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth Muir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Muir. The network helps show where Beth Muir may publish in the future.

Co-authorship network of co-authors of Beth Muir

This figure shows the co-authorship network connecting the top 25 collaborators of Beth Muir. A scholar is included among the top collaborators of Beth Muir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth Muir. Beth Muir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Smolen, Gromoslaw A., Benjamin Schott, Rodney A. Stewart, et al.. (2007). A Rap GTPase interactor, RADIL, mediates migration of neural crest precursors. Genes & Development. 21(17). 2131–2136. 38 indexed citations

Moran, Stewart T., Annaiah Cariappa, Haoyuan Liu, et al.. (2007). Synergism between NF-κB1/p50 and Notch2 during the Development of Marginal Zone B Lymphocytes. The Journal of Immunology. 179(1). 195–200. 60 indexed citations

Miao, Jiangyong, Zuncai Wang, Beth Muir, et al.. (2007). HOXB13 promotes ovarian cancer progression. Proceedings of the National Academy of Sciences. 104(43). 17093–17098. 98 indexed citations

Wang, Zuncai, Sonika Dahiya, Beth Muir, et al.. (2007). The Prognostic Biomarkers HOXB13, IL17BR, and CHDH Are Regulated by Estrogen in Breast Cancer. Clinical Cancer Research. 13(21). 6327–6334. 72 indexed citations

Smolen, Gromoslaw A., Beth Muir, Gayatry Mohapatra, et al.. (2006). Frequent Met Oncogene Amplification in a Brca1/Trp53 Mouse Model of Mammary Tumorigenesis. Cancer Research. 66(7). 3452–3455. 32 indexed citations

Kwak, Eunice L., Janusz Jankowski, Sarah P. Thayer, et al.. (2006). Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas. Clinical Cancer Research. 12(14). 4283–4287. 133 indexed citations

Hartwell, Kimberly A., Beth Muir, Ferenc Reinhardt, et al.. (2006). The Spemann organizer gene, Goosecoid , promotes tumor metastasis. Proceedings of the National Academy of Sciences. 103(50). 18969–18974. 167 indexed citations

Smolen, Gromoslaw A., Raffaella Sordella, Beth Muir, et al.. (2006). Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proceedings of the National Academy of Sciences. 103(7). 2316–2321. 401 indexed citations

Overholtzer, Michael, Jianmin Zhang, Gromoslaw A. Smolen, et al.. (2006). Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon. Proceedings of the National Academy of Sciences. 103(33). 12405–12410. 748 indexed citations breakdown →

10.

Cohen, Ezra E.W., Mark W. Lingen, Leslie E. Martin, et al.. (2005). Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation ofERBB2rather thanEGFR. Clinical Cancer Research. 11(22). 8105–8108. 104 indexed citations

11.

Bell, Daphne W., Thomas J. Lynch, Sara M. Haserlat, et al.. (2005). Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials. Journal of Clinical Oncology. 23(31). 8081–8092. 518 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact